ImClone Investigational Site

Baltimore, Maryland 21237

0 studies enrolling now · 8 studies all time

What they study most

Colorectal Cancer, Colorectal Neoplasms, Fallopian Tube Cancer, Head and Neck Cancer, Non Small Cell Lung Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Ovarian Neoplasms, Primary Peritoneal Carcinoma

Studies at this site

• First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin — Completed
• Study of Ramucirumab in Ovarian Cancer — Completed
• A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer — Completed
• Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed
• Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer — Completed
• A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer — Completed
• Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) — Completed